PolarCap® receives market approval for Australia
The medical technology company PolarCool AB (publ.) has received approval from the Australian Register of Therapeutic Goods (TGA) for the PolarCap® System. The approval enables the PolarCap® System to be sold and distributed in Australia by an Australian-based distributor. PolarCool develops the product PolarCap®, which alleviates the effects of concussions. The primary customers are sports clubs and facilities in ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion. The TGA approval includes a certificate for both the SmallCool unit